What’s News in Markets: Wegovy Pill, Salesforce AI Woes, BlackRock Record

17 Jan 2026 · 5 min · 5 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

WSJ Your Money Briefing Podcast Notes

Episode

What’s News in Markets: Wegovy Pill, Salesforce AI Woes, BlackRock Record

Episode Overview

  • Host: Jack Pitcher
  • Date: January 17
  • Main Themes: Market movements, significant corporate news, and economic indicators affecting investor sentiment.

Key Highlights

Market Sentiment

  • Calm Amidst Chaos: The week was characterized by calmness in the markets despite ongoing investigations and mixed earnings reports.
  • Federal Reserve Investigation:
  • Jerome Powell, the Federal Reserve Chair, is under investigation for his testimony regarding a renovation project, which raised concerns about the independence of the Fed and potential inflation risks.
  • Powell labeled the investigation as politically motivated, asserting it is part of an effort to influence Fed policy.

Earnings Season

  • Mixed results from major banks:
  • JP Morgan: Reported lower-than-expected investment banking revenue, disappointing investors.
  • Goldman Sachs & Morgan Stanley: Both firms showed strong quarterly performance.
  • Market Performance:
  • S&P 500 down 0.4% (near record high)
  • Dow Jones down 0.3%
  • Nasdaq composite down 0.7%

Wegovy Pill Launch (Novo Nordisk)

  • Stock Movement: Novo Nordisk shares surged following positive news regarding its weight loss drug, Wegovy.
  • Approval of a higher dosage by the UK health regulator.
  • Initial sales in the U.S. showed over 4,000 new prescriptions in a week.
  • Stock jumped 9% on Friday, closing the week up 6%.

AI Impact on Software Companies

  • Investor Concerns: Major software companies like Intuit, Salesforce, and Adobe faced declines in stock prices due to fears surrounding AI advancements.
  • Investor angst arises from the perception that AI could potentially replace traditional software solutions or eliminate the need for enterprise software.
  • Stock drops:
  • Intuit: -16%
  • Salesforce: -13%
  • Adobe: -11%

BlackRock's Record Assets

  • Growth in Assets: BlackRock reported a record $14 trillion in assets under management, driven by market gains and $700 billion in new client investments.
  • Positive investor sentiment following earnings report, with a nearly 6% increase in BlackRock shares, nearing record highs.

Conclusion

  • The episode encapsulated the significant market movements of the week, emphasizing the interplay between corporate earnings, regulatory concerns, and technological advancements affecting investor perceptions and decisions.

Additional Resources

  • For further details on market movements, visit [wsj.com](http://wsj.com).
  • Sign up for the WSJ's free Markets A.M. newsletter for daily updates.

Production Credits

  • Produced by Jess Fenton, with supervising producer Melanie Roy.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

Federal Reserve Investigation Impact

0:22 to 1:04

Discussion on the investigation of Jerome Powell and its market implications.

“That was the theme for markets this week.”

Earnings Season Overview

1:04 to 1:41

Overview of mixed earnings results from major banks during earnings season.

“Meanwhile, banks kicked off earnings season with a mixed bag of results.”

Novo Nordisk and Wegovy Developments

1:41 to 2:19

Updates on Novo Nordisk's Wegovy drug and its market performance.

“The U.K.'s health regulator approved a significantly higher dose of the drug for patients with a body mass index of at least 30.”

AI Concerns in Software Sector

2:19 to 3:04

Analysis of investor concerns regarding AI advancements affecting software companies.

“Intuit, the maker of TurboTax, Salesforce, a corporate software titan, and Adobe, which makes Photoshop and Acrobat, were all among the worst performers in the S &P 500 this week.”

BlackRock's Record Assets Under Management

3:04 to 3:41

BlackRock reports a record $14 trillion in assets and discusses its growth.

“The world's biggest investment firm keeps getting bigger.”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00Hey, listeners. Your Money Briefing is on a break, but it will be back with more personal finance information for you in the future. Until then, here's the news moving markets this week.

0:12Hey, listeners. It's Saturday, January 17. I'm Jack Pitcher for The Wall Street Journal. And this is What's News in Markets. Our look at the biggest stock moves of the week and the news that drove them. Let's get to it. Calm in the face of chaos. That was the theme for markets this week. On Sunday night, news broke that Federal Reserve Chair Jerome Powell is being investigated by U.S. prosecutors over his testimony about the central bank's building renovation project. In a video statement, Powell, who is usually quite restrained, called the investigation a pretext as part of President Trump's campaign to pressure the Fed to lower interest rates and end the independence of the central bank.

0:56Investors, concerned that a lack of Fed independence could lead to runaway inflation, have been closely watching the Powell situation. Meanwhile, banks kicked off earnings season with a mixed bag of results. JP Morgan disappointed investors with lower-than-expected investment banking revenue, but Goldman Sachs and Morgan Stanley posted strong quarters. At the index level, stocks inched lower for the week. The S &P 500 ended down 0.4%, just shy of a record high. The Dow fell 0.3%, while the Nasdaq composite was 0.7 % lower.

1:33Novo Nordisk shares jumped in the U.S. on Friday after a string of positive news about its flagship weight loss drug, Wagovi. The U.K.'s health regulator approved a significantly higher dose of the drug for patients with a body mass index of at least 30. The Danish drugmaker is awaiting regulatory approvals for the same size dose in the U.S. and the E.U. Meanwhile, sales of Novo's Wagovi pill just began in the U.S. Data released Friday showed the new pill generated more than 4 ,000 new prescriptions in the U.S. last week. A strong start, analysts said. Novo's American depository receipts jumped 9 % Friday and closed up 6 % for the week.

2:18AI is causing investor angst over the outlook for some major software companies. Intuit, the maker of TurboTax, Salesforce, a corporate software titan, and Adobe, which makes Photoshop and Acrobat, were all among the worst performers in the S &P 500 this week. None of the companies reported specific bad news, but analysts say rapid advancements in AI are creating a general sense of unease around software companies that were once thought to be invincible thanks to the widespread adoption of their products. AI is becoming very adept at coding software. Some investors now picture a future in which companies can use AI to handle tasks once outsourced to enterprise software.

2:58or simply build their own. For the week, Intuit shares fell 16%. Salesforce was 13 % lower, while Adobe dropped 11%.

3:11The world's biggest investment firm keeps getting bigger. BlackRock reported a record $14 trillion in assets under management on Thursday, and investors were pleased with fee growth that beat expectations. BlackRock primarily makes money through fees it charges to manage trillions of dollars for clients. Its assets grew to a record in 2025 on the back of market gains and$700 billion of new client money. BlackRock shares advanced almost 6 % after it reported earnings Thursday and closed the week near a record high. And now you know what's news in markets this week. You can read more about the week's market moves on wsj.com.

3:51Today's show is produced by Jess Fenton with supervising producer Melanie Roy. I'm Jack Pitcher. Have a great weekend.

From the publisher

Why are investors buzzing about Novo Nordisk’s Wegovy pill launch? And how has sentiment turned against software makers like Salesforce? Plus, what drove BlackRock’s asset pile to a record $14 trillion? Host Jack Pitcher discusses the biggest stock moves of the week and the news that drove them.

Sign up for the WSJ's free Markets A.M. newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

More from WSJ Your Money Briefing

All 57 episodes
What’s News in Markets: Wegovy Pill, Salesforce AI Woes, BlackRock RecordWSJ Your Money Briefing · 5 min
Listen in VO